CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Solid Biosciences wins new Outperform at RBC on DMD opportunity

Positive
AI Analysis

Summary

RBC Capital Markets initiated or upgraded Solid Biosciences to an Outperform rating, citing the company's duchenne muscular dystrophy (DMD) program opportunity.

Importance:3/10
Sentiment:
0.60
analyst_ratingDMDequity_research
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 16, 2026 4:15 PM

Read Original